PP_1170x120_10-25-21

John O’Brien is president and chief executive officer of the National Pharmaceutical Council.

PBMs’ outsize influence hurts the health care system

PBMs’ outsize influence hurts the health care system

The health of everyone in America who needs a prescription drug is increasingly dependent on a complex system in which pharmacy benefit managers exert an incredible amount of control. This system jeopardizes access to needed medicines and lacks meaningful competition, good reasons why the Federal Trade Commission is giving additional scrutiny. PBMs, as they are

New moves to shine more light into an opaque drug pricing system

New moves to shine more light into an opaque drug pricing system

The broad array of medicines available, from the newest innovation to the most tried-and-true generic, saves and improves the lives of patients everywhere, providing tremendous value. But the ecosystem in the United States that results in innovative medications being discovered and ultimately dispensed to patients at the pharmacy counter is hampered by an opaque pricing

Don’t limit innovation; it’s the only route to a healthier world

Don’t limit innovation; it’s the only route to a healthier world

The last 18 months have been a tremendous reminder of the positive impact that American health care innovation delivers for patients when stakeholders work together. The coronavirus pandemic has been a terrible tragedy that challenged all of us. But the way the American health system has stepped up to that challenge is inspiring. From manufacturing